Healthcare Services

Colorectal Cancer Molecular Diagnostics Industry Expansion Forecast Showing Market Size of $4.14 Billion by 2030 at 8.3% CAGR

March 31, 2026March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Colorectal Cancer Molecular Diagnostics Market Over The 2026–2030 Period?

The size of the colorectal cancer molecular diagnostics market has experienced substantial growth in recent years. This market is projected to expand from $2.78 billion in 2025 to $3.02 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.5%. Historically, this expansion has been attributed to several factors such as increasing colorectal cancer incidence rates, the broadening of diagnostic laboratory infrastructure, a rising adoption of molecular testing protocols, enhanced awareness concerning early screening, and the growing application of precision medicine approaches.

The colorectal cancer molecular diagnostics market is projected to experience robust expansion in the coming years. This market is anticipated to reach $4.15 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.3%. This growth during the forecast period is attributable to several factors, including escalating investments in precision oncology, a surge in demand for minimally invasive diagnostic methods, the broadening of genomic testing initiatives, the increasing incorporation of AI into cancer diagnostics, and a heightened emphasis on monitoring treatment responses. Key trends anticipated during this period encompass the wider adoption of molecular biomarker testing, the escalating utilization of PCR and sequencing technologies, a heightened demand for personalized oncology diagnostics, the expansion of companion diagnostic development, and a stronger focus on early cancer detection.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13120&type=smp

What Drivers Are Expected To Influence The Colorectal Cancer Molecular Diagnostics Market During The Forecast Period?

The expanding incidence of colorectal cancer is projected to fuel the advancement of the colorectal cancer molecular diagnostics market. Colorectal cancer, an ailment impacting the colon or rectum within the digestive system, develops when cells in these areas proliferate uncontrollably, leading to tumor formation. The growing occurrence of this cancer consequently elevates the need for molecular diagnostics in both its identification and management. For illustration, data from March 2023, supplied by the American Cancer Society, a US-based voluntary health organization focused on cancer eradication, indicates an estimated 153,020 individuals are anticipated to be diagnosed with CRC (colorectal cancer), with around 52,550 of them expected to die from the condition. Specifically, 19,550 cases and 3,750 deaths are predicted among individuals under 50 years old. Consequently, the increasing prevalence of colorectal cancer is a significant factor boosting the expansion of the colorectal cancer molecular diagnostics market.

How Is The Colorectal Cancer Molecular Diagnostics Market Segmented Across Key Categories?

The colorectal cancer molecular diagnostics market covered in this report is segmented –

1) By Type: Instruments, Reagents And Kits, Services

2) By Technology: Polymerase Chain Reaction (PCR), Sequencing, Mass Spectrometry, Transcription Mediated Amplification, Chips And Microarrays, Isothermal Nucleic Acid Amplification Technology (INAAT)

3) By End Users: Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories, Homecare Settings

Subsegments:

1) By Instruments: PCR Machines, Sequencers, Microarrays

2) By Reagents And Kits: DNA Or RNA Extraction Kits, Assay Kits, Reagent Packs

3) By Services: Diagnostic Testing Services, Genetic Testing Services, Consultation Services

How Are Trends Impacting The Colorectal Cancer Molecular Diagnostics Market?

Leading companies within the colorectal cancer molecular diagnostics market are dedicated to developing innovative solutions, such as blood-based liquid biopsy screening tests. This effort aims to address the increasing need for non-invasive, early detection methods, improve patient adherence compared to colonoscopy, and facilitate broader population screening as guidelines and reimbursement schemes progress. A liquid biopsy is a blood analysis designed to identify tumor-derived biomarkers from a straightforward blood draw; its principal characteristics include minimal invasiveness, the capability to screen asymptomatic populations, and molecular-level sensitivity that offers complementary benefits. For instance, in July 2024, Guardant Health, a United States-based precision oncology company, introduced Shield, a blood-based colorectal cancer screening test that gained approval from the U.S. Food and Drug Administration as a primary screening option for average-risk adults aged 45 and older. Shield operates as a multi-marker blood assay, scrutinizing circulating tumor signals to identify individuals likely to have colorectal cancer; it was developed and validated through the extensive ECLIPSE clinical programme, demonstrating impressive sensitivity and specificity suitable for FDA primary-screening designation. The test’s composition and operational mechanism integrate sequencing with proprietary bioinformatic classifiers to detect methylation and other tumor-derived signals in plasma. Its distinguishing attributes include convenience (requiring a single blood draw), the potential to enhance screening participation, and a clear path to Medicare coverage, with its applications covering population screening and the triage of positive results to diagnostic colonoscopy, thus enabling earlier detection with fewer invasive procedures.

Who Are The Dominant Players Shaping The Colorectal Cancer Molecular Diagnostics Market Landscape?

Major companies operating in the colorectal cancer molecular diagnostics market are Johnson & Johnson, Bayer AG, Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Biocartis Group NV, Agilent Technologies Inc., Grifols S.A, Hologic Inc., Biomérieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corporation, Illumina Inc., Cepheid, Myriad Genetics Inc., Guardant Health, Luminex Corporation, GenMark Diagnostics, Amoy Diagnostics Co. Ltd., MDxHealth Inc., HTG Molecular Diagnostics Inc., GenPath Diagnostics, geneOmbio Technologies Pvt.

Read the full colorectal cancer molecular diagnostics market report here:

https://www.thebusinessresearchcompany.com/report/colorectal-cancer-molecular-diagnostics-global-market-report

Which Region Is Forecast To Lead The Colorectal Cancer Molecular Diagnostics Market In Terms Of Market Size?

North America was the largest region in the colorectal cancer molecular diagnostics market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the colorectal cancer molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Colorectal Cancer Molecular Diagnostics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13120&type=smp

Browse Through More Reports Similar to the Global Colorectal Cancer Molecular Diagnostics Market 2026, By The Business Research Company

Pain Management Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report

Muscle Pain Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/muscle-pain-treatment-global-market-report

Chronic Pain Global Market Report

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795